Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behcet disease uveitis and concomitant bladder papillary carcinoma

被引：10
|
作者：
Orlando, Ida [1 ]
Vitale, Antonio [1 ]
Rigante, Donato [2 ]
Lopalco, Giuseppe [3 ]
Fabiani, Claudia [4 ]
Cantarini, Luca [1 ]
机构：
[1] Univ Siena, Dept Med Sci Surg & Neurosci, Res Ctr System Autoinflammatory Dis & Behcets Dis, Siena, Italy
[2] Univ Cattolica Sacro Cuore, Inst Pediat, A Gemelli Hosp, Rome, Italy
[3] Interdisciplinary Dept Med, Rheumatol Unit, Bari, Italy
[4] Humanitas Clin & Res Ctr, Dept Ophthalmol, Milan, Italy
来源：
INTERNAL MEDICINE JOURNAL | 2017年 / 47卷 / 09期
关键词：
GROWTH;
D O I：
10.1111/imj.13538
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1086 / 1088
页数：4
相关论文
共 50 条
  • [21] Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behcet's Disease: A Case Series
    Vitale, Antonio
    Rigante, Donato
    Caso, Francesco
    Brizi, Maria Giuseppina
    Galeazzi, Mauro
    Costa, Luisa
    Franceschini, Rossella
    Lucherini, Orso Maria
    Cantarini, Luca
    DERMATOLOGY, 2014, 228 (03) : 211 - 214
  • [22] LONG-TERM EFFICACY AND SAFETY OF LOW DOSE AND DOSE ESCALATING INTERFERON ALFA-2A THERAPY IN REFRACTORY BEHCET'S UVEITIS
    Onal, Sumru
    Kazokoglu, Haluk
    Koc, Aylin
    Akman, Mehmet
    Bavbek, Tayfun
    Direskenell, Haner
    Yavuz, Sule
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S147 - S147
  • [23] Interleukin-1 receptor antagonist anakinra proves long-lasting efficacy in the treatment of refractory adult onset still's disease
    Naumann, L.
    Feist, E.
    Natusch, A.
    Krause, A.
    Buttgereit, F.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 434 - 435
  • [24] Long-term efficacy and safety of golimumab in the treatment of multirefractory Behcet's disease
    Vitale, Antonio
    Emmi, Giacomo
    Lopalco, Giuseppe
    Fabiani, Claudia
    Gentileschi, Stefano
    Silvestri, Elena
    Gerardo, Di Scala
    Iannone, Florenzo
    Frediani, Bruno
    Galeazzi, Mauro
    Lapadula, Giovanni
    Rigante, Donato
    Cantarini, Luca
    CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 2063 - 2069
  • [25] Long-Term Efficacy of Interleukin-1 Receptor Antagonist (Anakinra) in Corticosteroid-Dependent and Colchicine-Resistant Recurrent Pericarditis
    Finetti, Martina
    Insalaco, Antonella
    Cantarini, Luca
    Meini, Antonella
    Breda, Luciana
    Alessio, Maria
    D'Alessandro, Matteo
    Picco, Paolo
    Martini, Alberto
    Gattorno, Marco
    JOURNAL OF PEDIATRICS, 2014, 164 (06): : 1425 - +
  • [26] Long-term clinical outcomes in patients with refractory uveitis associated with Behcet's disease treated with infliximab
    Abu El Asrar, A.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [27] Long-term efficacy and safety of adalimumab in Behcet's disease patients with non-infectious uveitis in the VISUAL III trial
    Fortin, E.
    van Calster, J.
    Goto, H.
    Namba, K.
    Douglas, K.
    Kron, M.
    Song, A.
    Pathai, S.
    Bodaghi, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S174 - S175
  • [28] Long-Term Efficacy and Safety of Tumour Necrosis Factor Antagonists for Patients with Behcet's Disease with Uveitis As Main Involvement.
    Victoria Hernandez, M.
    Mesquida, Marina
    Espinosa, Gerard
    Llorens, Victor
    Pelegrin, Laura
    Canete, Juan D.
    Cervera, Ricard
    Adan, Alfredo M.
    Sanmarti, Raimon
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S80 - S80
  • [29] Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study
    Niccoli, L.
    Nannini, C.
    Benucci, M.
    Chindamo, D.
    Cassara, E.
    Salvarani, C.
    Cimino, L.
    Gini, G.
    Lenzetti, I.
    Cantini, F.
    RHEUMATOLOGY, 2007, 46 (07) : 1161 - 1164
  • [30] THE INTERLEUKIN-1B INHIBITOR CANAKINUMAB FOR REFRACTORY STILL'S DISEASE: LONG-TERM EXPERIENCE IN 50 CONSECUTIVE PATIENTS
    Laskari, K.
    Athanassiou, P.
    Georgiadis, A.
    Gerodimos, C.
    Gkoni, G.
    Daoussis, D.
    Dimitroulas, T.
    Dimopoulou, D.
    Iliou, C.
    Kallitsakis, I.
    Karamitsos, D.
    Katsiari, C.
    Liossis, S. N.
    Mavragani, C.
    Papagoras, C.
    Pikazis, D.
    Raftakis, I.
    Sarikoudis, T.
    Settas, L.
    Sidiropoulos, P.
    Soukera, D.
    Theodorou, E.
    Tsatsani, P.
    Tsiakou, E.
    Vassilopoulos, D.
    Vlachoyiannopoulos, P.
    Vosvotekas, G.
    Voulgari, P. V.
    Zakalka, M.
    Tektonidou, M.
    Sfikakis, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 841 - 841
12345